A next-generation treatment from Novo Nordisk helped patients with diabetes lower their blood sugar and lose weight in a ...

The lung cancer screening system “is not a risk assessment. It is a judgment system designed as one,” writes the director of ...

Like an estimated 20 million Americans, I have an incurable post-acute infection syndrome that goes by the name of long Covid ...

A federal commission is calling for significant changes to the way the U.S. government funds and assesses scientific research ...

Medicare officials have backed off a plan that would have clawed back $7.8 billion from hospitals a decade sooner than ...

With backlash growing to surging health insurance costs, Trump is floating a temporary extension of extra ACA subsidies.

Friends…hello. I’m BACK. My wife and I welcomed a new baby a few months ago. We now have two kids (still weird to say kids, ...

Novo Nordisk's blockbuster weight loss drug semaglutide failed to slow Alzheimer's progression in trials. The studies had ...

A promising Alzheimer’s treatment failed to slow the progress of the disease, news that could dampen enthusiasm for a new class of potential medicines.

Novo Nordisk’s weight loss drug semaglutide failed to slow the progression of Alzheimer’s disease in two large trials ...

Novo Nordisk said this morning that a pair of large, placebo-controlled clinical trials testing an oral version of its GLP-1 ...

The Capitol Hill battle over hemp products underscores the concerns about the increasingly wild market and the widespread ...